Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer.
Alexander B OlawaiyeJae-Weon KimAndrea BagameriErin BishopAnita Chudecka-GłazAlix DevauxLaurence GladieffMary E GordinierJacob KorachMichael E McCollumLinda R MileshkinBradley J MonkShibani NicumAngélica N RodriguesAna OakninDavid M O'MalleyMauro OrlandoLyndah DreilingIulia C TudorDomenica LorussoPublished in: Journal of gynecologic oncology (2024)
ClinicalTrials.gov Identifier: NCT05257408; European Union Drug Regulating Authorities Clinical Trials Database Identifier: 2022-000662-18.